This country profile provides an overview of Rwanda’s progress in reaching those in need of mass NTD treatment based on 2016 data.
NTD mass treatment coverage index: 3/100
Overall rank: Joint 33rd
These recommendations were given to heads of state at the African Union summit in January 2017 as part of the ALMA Scorecard for Accountability and Action.
- Given the high coverage of soil-transmitted helminths (STH) preventive chemotherapy (PC) already achieved, implement PC for schistosomiasis alongside STH, at least for school-aged children and start elimination mapping for onchocerciasis.
- Increase budget allocation for neglected tropical diseases at the national level.
- Provide timely data to the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) to enable monitoring and planning.
Rwanda does not require mass treatment for lymphatic filariasis.
Rwanda does not require mass treatment for onchocerciasis.
⬇️ Treatment coverage decreased from 23% in 2015 to 0% in 2016.
⬆️ Treatment coverage increased from 99% in 2015 to 100% in 2016.
Rwanda does not require mass treatment for trachoma.